Phase I Trial of Albumin-bound Paclitaxel (A), Cisplatin (P) and 5-Fluorouracil (F) as Induction Chemotherapy (IC) Followed by Concurrent Chemoradiotherapy (CRT) With Carboplatin (Cb) in Patients (pts) With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)

被引：0
|
作者：
Diaz-Padilla, I.
Waldron, J. [1 ]
Hope, A. [1 ]
Chen, E. X.
Chan, K.
Kim, J. [1 ]
O'Sullivan, B. [1 ]
Razak, A. R. Abdul
Chin, S. F. [1 ]
Siu, L. L.
机构：
[1] Princess Margaret Hosp, Radiat Med Program, Toronto, ON M4X 1K9, Canada
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S547 / S547
页数：1
相关论文
共 50 条
  • [31] Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Katori, Hideaki
    Tsukuda, Mamoru
    Watai, Kiichi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (03) : 399 - 406
  • [32] Phase I study of cetuximab in combination with cisplatin or carboplatin and 5-fluorouracil (5-FU) in patients (pts) with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN).
    Humblet, Y
    Vega-Villegas, E
    Mesia, R
    Awada, A
    Geoffrois, L
    Borel, C
    Hitt, R
    Amellal, N
    Bessa, EH
    Bourhis, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 491S - 491S
  • [33] Efficacy and safety of a cisplatin and paclitaxel induction regimen followed by chemoradiotherapy for patients with locally advanced head and neck squamous cell carcinoma
    Viana, Luciano de Souza
    de Aguiar Silva, Felipe Coelho
    dos Anjos Jacome, Alexandre Andrade
    Campelo Maia, Danielle Calheiros
    de Mattos, Marcos Duarte
    Jacinto, Alexandre Arthur
    Mamere, Augusto Elias
    Boldrini Junior, Domingos
    de Castro Capuzzo, Renato
    Santos, Carlos Roberto
    Carvalho, Andre Lopes
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E970 - E980
  • [34] A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck
    Enokida, Tomohiro
    Ogawa, Takenori
    Homma, Akihiro
    Okami, Kenji
    Minami, Shujiro
    Nakanome, Ayako
    Shimizu, Yasushi
    Maki, Daisuke
    Ueda, Yuri
    Fujisawa, Takao
    Motegi, Atsushi
    Ohkoshi, Akira
    Taguchi, Jun
    Ebisumoto, Koji
    Nomura, Shogo
    Okano, Susumu
    Tahara, Makoto
    CANCER MEDICINE, 2020, 9 (05): : 1671 - 1682
  • [35] Randomized phase II/III clinical trial of induction chemotherapy (ICT) with either cisplatin/5-fluorouracil (PF) or docetaxel/cisplatin/5-fluorouracil (TPF) followed by chemoradiotherapy (CRT) vs. crt alone for patients (pts) with unresectable locally advanced head and neck cancer (LAHNC).
    Hitt, R.
    Grau, J.
    Lopez-Pousa, A.
    Berrocal, A.
    Garcia-Giron, C.
    Belon, J.
    Sastre, J.
    Martinez-Trufero, J.
    Cortes-Funes, H.
    Cruz-Hernandez, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 283S - 283S
  • [36] Ototoxicity in locally advanced head and neck cancer (LAHNC) patients (pts) treated with induction chemotherapy (IC) followed by cisplatin-based chemoradiotherapy (CRT)
    Driessen, C.
    Snik, A.
    Leijendeckers, J.
    de Boer, J. P.
    Gelderblom, H.
    van Opstal, C.
    van der Graaf, W.
    Kaanders, J.
    van Herpen, C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [37] A Single-institution Comparison of Cetuximab, Carboplatin, and Paclitaxel Induction Chemotherapy Followed by Chemoradiation (CRT) Versus CRT for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN)
    Grover, Surbhi
    Mitra, Nandita
    Wan, Fei
    Lukens, John N.
    Sharma, Sonam
    Bauman, Jessica
    Masroor, Farzad
    Cohen, Roger B.
    Desai, Arati
    Algazy, Kenneth
    Alonso-Basanta, Michelle
    Ahn, Peter
    Teo, Boon-Keng Kevin
    Chalian, Ara A.
    Weinstein, Gregory S.
    O'Malley, Bert W., Jr.
    Lin, Alexander
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (05): : 522 - 527
  • [38] Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck
    Hussain, M
    Gadgeel, S
    Kucuk, O
    Du, W
    Salwen, W
    Ensley, J
    CANCER, 1999, 86 (11) : 2364 - 2369
  • [39] Economic evaluation of the TAX 324 trial comparing docetaxel plus cisplatin and 5-fluorouracil (TPF) versus standard treatment with cisplatin and 5-fluorouracil (PF) as induction chemotherapy followed by concurrent chemoradiation therapy in locally advanced squamous cell carcinoma of the head and neck (SCCHN)
    Parthan, A.
    Posner, M. R.
    Brammer, C.
    Beltran, P.
    Jansen, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN)
    Baghi, M
    Hambek, M
    Wagenblast, J
    May, A
    Wolfgang
    Gstoettner
    Knecht, R
    ANTICANCER RESEARCH, 2006, 26 (1B) : 585 - 590
12345